Merchant Group increases stake in Rhythm Biosciences
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Specialist life sciences fund Merchant Group raised its ownership in Rhythm Biosciences Ltd. to 7.01% from 5.02%.
Merchant made its initial investment in the Australia-based medical diagnostics company June 12.
